Airway soluble CSF1R predicts progression in patients with idiopathic pulmonary fibrosis

• Justin M. Oldham,
• Kirk W. Johnson,
• Gesa J. Albers,
• Emily Calamita,
• Jordina Mah,
• Poonam Ghai,
• Richard J. Hewitt,
• Toby M. Maher,
• Philip L. Molyneaux,
• Michael Huang,
• Adam J. Byrne

Affiliations

Justin M. Oldham

Department of Internal Medicine, Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA

Kirk W. Johnson

AmMax Bio, Inc., Redwood City, CA, USA

Gesa J. Albers

National Heart and Lung Institute, Imperial College London, London, UK

Emily Calamita

National Heart and Lung Institute, Imperial College London, London, UK

Jordina Mah

National Heart and Lung Institute, Imperial College London, London, UK

Poonam Ghai

National Heart and Lung Institute, Imperial College London, London, UK

Richard J. Hewitt

National Heart and Lung Institute, Imperial College London, London, UK

Toby M. Maher

National Heart and Lung Institute, Imperial College London, London, UK

Philip L. Molyneaux

National Heart and Lung Institute, Imperial College London, London, UK

Michael Huang

AmMax Bio, Inc., Redwood City, CA, USA

Adam J. Byrne

National Heart and Lung Institute, Imperial College London, London, UK